EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 73 filers reported holding EDGEWISE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $236,225 | -41.7% | 41,226 | -21.2% | 0.00% | – |
| Q2 2023 | $405,332 | +11.4% | 52,301 | -4.2% | 0.00% | – |
| Q1 2023 | $364,002 | -22.6% | 54,573 | +3.8% | 0.00% | – |
| Q4 2022 | $470,066 | +261.6% | 52,580 | +297.3% | 0.00% | – |
| Q3 2022 | $130,000 | -59.1% | 13,233 | -66.8% | 0.00% | – |
| Q2 2022 | $318,000 | +19.1% | 39,918 | +44.9% | 0.00% | – |
| Q1 2022 | $267,000 | -39.3% | 27,550 | -4.3% | 0.00% | – |
| Q4 2021 | $440,000 | +856.5% | 28,786 | +950.6% | 0.00% | – |
| Q3 2021 | $46,000 | – | 2,740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $8,902,478 | 11.43% |
| Novo Holdings A/S | 6,071,703 | $34,790,858 | 2.57% |
| Orbimed Advisors | 14,567,176 | $83,469,918 | 1.77% |
| Opaleye Management Inc. | 875,405 | $5,016,071 | 1.63% |
| Cormorant Asset Management, LP | 2,946,887 | $16,885,663 | 0.98% |
| DAFNA Capital Management LLC | 519,384 | $2,976,070 | 0.93% |
| EcoR1 Capital, LLC | 3,493,194 | $20,016,002 | 0.68% |
| Deep Track Capital, LP | 2,750,000 | $15,757,500 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $22,536,875 | 0.50% |
| Parkman Healthcare Partners LLC | 473,312 | $2,712,078 | 0.50% |